Phacilitate Leaders Forum

17th - 18th SEPTEMBER 2019



Diego Ardigo

Diego Ardigo

Head R&D Rare Diseases Unit Head, Chiesi Farmaceutici SpA

Dr Diego is project leader for advanced therapies at Chiesi Farmaceutici. He is M.D and Ph.D by training, with clinical and laboratory research experience in Italy at the University of Parma and the U.S at Stanford University. Ardigo has authorised over 40 indexed papers. He joined Chiesi in 2010 as Clinical Leaders. He was the clinical lead of the first stem cell therapy approved in Europe (Holoclar) and leads the cross-company (Chiesi and uniQure B.V) team of the first gene therapy approved in Europe (Glybera). He is a member of the scientific Committee of IRDiRC and of the Advanced Therapy Joint Working Group of EBE-EFPIA.

  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd